Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2020 Sep 18;86(4):535–545. doi: 10.1007/s00280-020-04145-6

Fig. 3.

Fig. 3.

A) Human liver microsomal production of 6-α-OH-paclitaxel in the absence (□) and presence (■) of iohexol (P=0.69), and 3-p-OH-paclitaxel in the absence (△) and presence (▲) of iohexol (P=0.69) (mean of N=4 with SD error bars). B) Human liver cytosolic production of dFdU in the absence (○) and presence (●) of iohexol (P=0.83) (mean of N=3 with SD error bars).